Gout
Pipeline Therapies for Urate Lowering: Dr. Michael Pillinger
Dr. Pillinger reviews abstract #0675 and #0690 presented at the 2020 ACR annual meeting.
Pegloticase in Severe Refractory Gout: Dr. Olga Petryna
Dr. Petryna reviews several pegloticase-related abstracts presented at the ACR 2020 annual meeting, including abstracts #0683 and #0677.
Improving Response to Pegloticase: Dr. Nicola Dalbeth
Auckland-based rheumatologist Dr. Nicola Dalbeth discusses improving responses to the use of Pegloticase, including abstracts #0677 and #0952.
GCAN Report: Gout, Urate and the repositioning of innate immunity: Dr. Michael Pillinger
NYU's Dr. Michael Pillinger promises deeper looks at ACR 2020 activity regarding gout, but starts out reporting data from GCAN.
Advanced Imaging for Crystal Arthritis: Which Test is Best? Dr. Nicola Dalbeth
Dr. Nicola Dalbeth of Aukland, New Zealand examines abstracts #0647 and #1542 involving imaging studies for crystal arthritis at ACR 2020.
Crystal Arthritis and Gout Highlights at ACR: Dr. Nicola Dalbeth
Gout specialist Dr. Nicola Dalbeth from Aukland, New Zealand provides a preview perspective on crystal arthritis and gout studies and sessions at ACR 2020.
The RECIPE Study - MMF in Refractory Gout: Dr. Jack Cush
Dr. Jack Cush previews the RECIPE study, wherein MMF is used to blunt the immunogenicity of pegloticase (abstract #0952 presented at the ACR 2020 annual meeting).
Poster Hall